Ginkgo Bioworks (NYSE:DNA) today confirmed that it has collected, identified, and sequenced three samples containing the novel BA.3 sublineage of the Omicron variant. Samples came from passengers on flights originating
XpresSpa Group, Inc. (NASDAQ:XSPA) ("XpresSpa" or the "Company"), a health and wellness company, today announced through a joint effort with the Centers for Disease Control and Prevention (CDC) and